Amelioration of experimental hyperlipidemia in rats by Portulaca oleracea Linn from Kashmir Himalaya
Amelioration of experimental hyperlipidemia in rats by Portulaca oleracea Linn from Kashmir Himalaya
Blog Article
Background: Traditionally, Portulaca oleracea Linn.treats abscesses and dysentery as well as liver disease.Additionally, recent studies have reported its effectiveness as a neuroprotective, analgesic, anti-inflammatory, bronchodilator, anti-cancer, antioxidant, and curative, in addition to its pharmacological effects.Aim and Objective: To assess the phytochemical constituents quantitatively & qualitatively and lipid-lowering potential of different extracts of Portulaca oleracea L.
from Kashmir Himalaya.Methods: Portulaca oleracea L.was extracted with chloroform, methanol, and aqueous solvents.Qualitative and quantitative phytochemical screening was carried and antihyperlipidemic activity b-0665-cr-bstr was evaluated in experimental hyperlipidemic rats fed with cholesterol in coconut oil for 14 days.
Results: Chloroform, methanol, and aqueous extracts showed the presence of alkaloids, sapon ins, tannins, cardiac glycosides, terpenes, flavonoids, phenolic compounds, proteins, and carbohydrates.Quantitatively the dried plant powder contains alkaloids 0.72 g%, saponins 1.0 g%, phenolics 1.
09 g%, tannins 0.91 g%, carbohydrates 0.53 g%, proteins 0.25 g% and lipids 0.
87 g%.The aqueous extract was found to decrease the plasma total cholesterol, triglyceride, low-density lipoprotein-cholesterol, very lowdensity lipoprotein-cholesterol levels, LDL-C/HDL-C ratio and significantly elevated the high-density lipoprotein-cholesterol levels as compared to methanol and chloroform extracts against cholesterol-induced hyperlipidemic rats.Conclusions: The results reveal that the Portulaca oleracea L.from the Kashmir region possesses alkaloids, saponins, phenolics, tannins, carbohydrates, proteins and lipids and aqueous extract of Portulaca oleracea L.
at a dose of 200 mg/kg body weight possess highly significant antihyperlipidemic action than methanolic and chloroform rcma ko series extracts at similar doses.